Waltham biotech Morphic signs $725M partnership with Janssen
February 21, 2019 at 06:59 AM EST
Preclinical biotech Morphic Therapeutic Inc. has signed its second major collaboration with a pharmaceutical giant, announcing a collaboration with Janssen Thursday worth more than $725 million.